Poly(ADP-Ribose) Polymerase 1 (PARP1) Overexpression in Human Breast Cancer Stem Cells and Resistance to Olaparib

• Marine Gilabert ,

  Contributed equally to this work with: Marine Gilabert, Simon Launay

  Affiliations Institut Paoli-Calmettes, Department of Molecular Pharmacology, Marseille, France, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille, France, Aix-Marseille University, Marseille, France, Centre de Recherche en Cancérologie de Marseille, U1068 INSERM, U7258 CNRS, Marseille, France

  ⨯
• Simon Launay ,

  Contributed equally to this work with: Marine Gilabert, Simon Launay

  Affiliations Institut Paoli-Calmettes, Department of Medical Oncology, Marseille, France, Institut Paoli-Calmettes, Department of Molecular Oncology, Marseille, France

  ⨯
• Christophe Ginestier,

  Affiliations Institut Paoli-Calmettes, Department of Molecular Oncology, Marseille, France, Centre de Recherche en Cancérologie de Marseille, U1068 INSERM, U7258 CNRS, Marseille, France

  ⨯
• François Bertucci,

  Affiliations Institut Paoli-Calmettes, Department of Medical Oncology, Marseille, France, Institut Paoli-Calmettes, Department of Molecular Oncology, Marseille, France, Aix-Marseille University, Marseille, France, Centre de Recherche en Cancérologie de Marseille, U1068 INSERM, U7258 CNRS, Marseille, France

  ⨯
• Stéphane Audebert,

  Affiliations Institut Paoli-Calmettes, Department of Molecular Pharmacology, Marseille, France, Centre de Recherche en Cancérologie de Marseille, U1068 INSERM, U7258 CNRS, Marseille, France

  ⨯
• Mathieu Pophillat,

  Affiliations Institut Paoli-Calmettes, Department of Molecular Pharmacology, Marseille, France, Centre de Recherche en Cancérologie de Marseille, U1068 INSERM, U7258 CNRS, Marseille, France

  ⨯
• Yves Toiron,

  Affiliations Institut Paoli-Calmettes, Department of Molecular Pharmacology, Marseille, France, Centre de Recherche en Cancérologie de Marseille, U1068 INSERM, U7258 CNRS, Marseille, France

  ⨯
• Emilie Baudelet,

  Affiliations Institut Paoli-Calmettes, Department of Molecular Pharmacology, Marseille, France, Centre de Recherche en Cancérologie de Marseille, U1068 INSERM, U7258 CNRS, Marseille, France

  ⨯
• Pascal Finetti,

  Affiliations Institut Paoli-Calmettes, Department of Molecular Oncology, Marseille, France, Centre de Recherche en Cancérologie de Marseille, U1068 INSERM, U7258 CNRS, Marseille, France

  ⨯
• Tetsuro Noguchi,

  Affiliation Institut Paoli-Calmettes, Department of Cancer Genetics, Marseille, France

  ⨯
• Hagay Sobol,

  Affiliations Institut Paoli-Calmettes, Department of Cancer Genetics, Marseille, France, Aix-Marseille University, Marseille, France

  ⨯
• Daniel Birnbaum,

  Affiliations Institut Paoli-Calmettes, Department of Molecular Oncology, Marseille, France, Centre de Recherche en Cancérologie de Marseille, U1068 INSERM, U7258 CNRS, Marseille, France

  ⨯
• Jean-Paul Borg,

  Affiliations Institut Paoli-Calmettes, Department of Molecular Pharmacology, Marseille, France, Aix-Marseille University, Marseille, France, Centre de Recherche en Cancérologie de Marseille, U1068 INSERM, U7258 CNRS, Marseille, France

  ⨯
• Emmanuelle Charafe-Jauffret,

  Affiliations Institut Paoli-Calmettes, Department of Biopathology, Marseille, France, Institut Paoli-Calmettes, Department of Molecular Oncology, Marseille, France, Aix-Marseille University, Marseille, France, Centre de Recherche en Cancérologie de Marseille, U1068 INSERM, U7258 CNRS, Marseille, France

  ⨯
• Anthony Gonçalves

  * E-mail: goncalvesa@ipc.unicancer.fr

  Affiliations Institut Paoli-Calmettes, Department of Molecular Pharmacology, Marseille, France, Institut Paoli-Calmettes, Department of Medical Oncology, Marseille, France, Aix-Marseille University, Marseille, France, Centre de Recherche en Cancérologie de Marseille, U1068 INSERM, U7258 CNRS, Marseille, France

  ⨯